Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

COVID-19 in Polish Ice Swimmers. (ICE)

6 avril 2021 mis à jour par: Wroclaw Medical University

Influence of Ice Swimming on Hardening Against SARS-CoV-2 and Influence of AB0 Rh Blood Type on Viral Resistance in Polish Ice Swimmers.

Ice swimming is an increasingly common phenomenon in Poland. It has been confirmed that it has a beneficial effect on health by increasing the natural non-specific immunity to infections. In the face of the current Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic causing Coronavirus Disease 2019 (COVID-19), researchers decided to use a survey to check the incidence of COVID-19 among Polish ice swimmers, as well as recent ailments. Then, the researchers will compare the obtained results with epidemiological data for Poland.Researchers will also investigate the relationship between susceptibility to SARS-CoV-2 infection and the blood group and Rh factor among ice swimmers.

Aperçu de l'étude

Description détaillée

The research tool is an original questionnaire compiled by a team of experts conducting the study. The survey includes questions about sociodemographic data, such as age and gender and blood type in AB0 system with Rh factor, and questions about the frequency of ice swimming, the duration of a single session, and since when respondents have been ice swimming. There was also a question about the respondents' compliance with the restrictions and recommendations related to the pandemic and contacts with people with confirmed SARS-CoV-2 infection. In the survey, researchers ask about the infectious symptoms experienced during the pandemic and about being diagnosed with COVID-19 or its exclusion. People who have been ill are asked about the place of treatment.

The questionnaires are collected in traditional form, on the Internet and as scans of documents. Each survey was completely anonymous. The obtained statistical data will be compared with official data on new COVID-19 cases and recoveries at the same time. Official data are published by the Ministry of Health and earlier also by Sanitary and Epidemiological Stations. The main aim of the study was to determine whether ice swimming also increases resistance to SARS-CoV-2 and COVID-19.

Type d'étude

Observationnel

Inscription (Réel)

2534

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Dolny Slask
      • Wrocław, Dolny Slask, Pologne, 51-618
        • Department of Public Health at Wroclaw Medical University
    • Lubuskie
      • Gorzów Wielkopolski, Lubuskie, Pologne, 66-400
        • Department of Radiotherapy of Multidisciplinary Provincial Hospital
      • Zielona Góra, Lubuskie, Pologne, 65-031
        • Treasury Medical Company

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Enfant
  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

Surveys are distributed en masse among ice swimmers from Poland. Comparative data for the control group is derived from officially published national and regional pandemic data.

La description

Inclusion Criteria:

  • ice swimmers

Exclusion Criteria:

  • not active ice swimmers

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Ice Swimmers Group.
No intervention. Data obtained from Polish ice swimmers reported by them retrospectively in the questionnaire.
The intervention is not made in the course of a research study. Ice swimming has been introduced earlier by a given group. The group was made up of people who already swim in ice.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Assessment of the incidence of COVID-19 among ice swimmers compared to the general population.
Délai: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the frequency of asymptomatic SARS-CoV-2 infection among ice swimmers compared to the general population.
Délai: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the frequency of occurrence of particular symptoms of SARS-CoV-2 infection among ice swimmers compared to the general population.
Délai: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the frequency of COVID-19 treatment in an outpatient, inpatient and intensive care unit among ice swimmers compared to the general population.
Délai: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.
Assessment of the impact of parameters and ice swimming strategies on the likelihood of developing COVID-19, the occurrence of individual symptoms of the disease and the severity of its course.
Délai: 47 days.
Inference from data obtained from surveys collected among ice swimmers.
47 days.
Assessment of the influence of blood group on susceptibility to SARS-CoV-2 infection among ice swimmers.
Délai: 47 days.
Inference from data obtained from surveys collected among ice swimmers.
47 days.

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Assessment of the immunity of the ice swimmer's immune system compared to the general population.
Délai: 47 days.
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
47 days.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Directeur d'études: Sylwia Sulimiera Michalak, MD, PhD, Department of Pharmacology and Toxicology, Medical University of Zielona Gora
  • Directeur d'études: Edyta Wolny-Rokicka, MD, PhD, Department and Center of Radiotherapy, Multidisciplinary Provincial Hospital in Gorzow Wielkopolski
  • Chaise d'étude: Andrzej Tukiendorf, Prof., Department of Public Health, Wroclaw Medical University
  • Chercheur principal: Lukasz K Wysoczanski, MD, Department of Family Medicine, Wroclaw Medical University
  • Chercheur principal: Paulina N Wysoczanska, MD, Department of Family Medicine, Wroclaw Medical University

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 décembre 2020

Achèvement primaire (Réel)

17 janvier 2021

Achèvement de l'étude (Réel)

1 mars 2021

Dates d'inscription aux études

Première soumission

24 mars 2021

Première soumission répondant aux critères de contrôle qualité

25 mars 2021

Première publication (Réel)

26 mars 2021

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

9 avril 2021

Dernière mise à jour soumise répondant aux critères de contrôle qualité

6 avril 2021

Dernière vérification

1 avril 2021

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

Essais cliniques sur Covid19

Essais cliniques sur Ice Swimming

3
S'abonner